ZYIL1 (Usnoflast) is a selective NLRP3 inflammasome inhibitor that has been shown to decrease CAPS disease activity and improve symptoms in a mouse model of Parkinson’s disease [373, 374]. The gene discussed is NLRP3; the disease is Parkinson disease.